title: [New therapeutic strategy for autoimmune diseases. 2) Abnormality in expression of cell surface molecules in systemic erythematodes and its therapeutic application].
authors.forename: Y
authors.initials: Y
authors.lastname: Takasaki
authors.forename: K
authors.initials: K
authors.lastname: Abe
authors.forename: Y
authors.initials: Y
authors.lastname: Tokano
authors.forename: H
authors.initials: H
authors.lastname: Hashimoto
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018122:B7-1 Antigen / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008180:Lupus Erythematosus, Systemic / Q000276:immunology* / Q000628:therapy; D016169:Lymphocyte Function-Associated Antigen-1 / Q000097:blood*; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D016513:Mice, SCID
chemical_list: D000911:Antibodies, Monoclonal; D018122:B7-1 Antigen; D016169:Lymphocyte Function-Associated Antigen-1; D018799:Intercellular Adhesion Molecule-1